Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivoGerke Ariaans(University of Groningen), Mathilde Jalving(University Medical Center Groningen)Biomedicine & PharmacotherapyMarch 2, 202410.1016/j.biopha.2024.116362Cited by 4SaveCiteExport RISWatch citationsRelated PapersLong-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers|Gynecologic Oncology|2024|2